Images

[From aidsmap, June 19, 2019] “Drug-drug interactions are common in people over the age of 65 living with HIV and this substantially increases healthcare costs in France. Published in Open Forum Infectious Diseases, a new study has revealed that as many as 17% of ageing individuals had an identified drug-drug interaction, costing as much as […]

[From Monthly Prescribing Reference, June 19, 2019] “The Food and Drug Administration (FDA) has approved updated labeling for Biktarvy (bictegravir, emtricitabine, and tenofovir alafenamide; Gilead) to include treatment of both adult and pediatric patients weighing at least 25kg with HIV-1 who have no antiretroviral treatment history or to replace the current antiretroviral regimen in those

[From CTV, June 19, 2019] “A recent update to an ongoing study found that, while deaths due to HIV continue to decline among gay and bisexual men in Canada, deaths by suicide are not. This is prompting the lead researcher, Travis Salway, to renew his call for more available mental health resources, particularly at STI

[From Vice, June 18, 2019] “When you tell someone that you’re HIV positive, the question they always want to ask is “how did you get it?” Some people just come right out and say it. Others are polite enough not to ask, but you can see the question sitting there, lingering behind their eyes. So

[From aidsmap, June 18, 2019] “A study of people prescribed PrEP over a four-year period at a large centre in Los Angeles has found that HIV incidence in people taking PrEP was more than 95% lower than among service users who discontinued PrEP, and at least 92% lower than among the clinic population in general.”